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The Consumer Protection Act of 2008 has had far-reaching consequences for suppliers of goods and services in South Africa. The 
implementation of the Act has important implications for all suppliers who enter into ‘consumer transactions’. This article aims to 
stimulate awareness of the legal consequences of the Act arising from day-to-day situations occurring in the pharmacy, and to highlight the 
compliance obligations that the Act creates for pharmacists.
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The purpose of the Consumer Protection Act 
(CPA),[1] in so many words, is to promote and 
advance the social and economic welfare of 
consumers in South Africa (SA). Specific protection 
is given to certain classes of people such as the 
illiterate, minors, seniors, people living in remote areas and those of 
low income. Most of the provisions of the Act came into effect on 
1 April 2011. The provisions of the Act relating to harm caused to 
consumers by defective products apply only to goods supplied on or 
after 1 April 2011.
Interpretation of any law must promote the spirit and the 
objectives of the Bill of Rights,[2] which protects the fundamental 
rights of every person in SA, and the CPA is no exception to this 
rule. For example, a pharmacist may not discriminate unfairly 
between patients by prioritising supply of medicines, supplying 
goods or services of different quality, or charging different prices 
to different patients on the grounds of race, gender, pregnancy, 
marital status, ethnic or social origin, colour, sexual orientation, 
age, disability, religion, conscience, belief, culture, language or birth. 
Furthermore, to protect his or her right to privacy the consumer 
may refuse to be contacted for purposes of direct marketing through 
electronic and postal advertising media. The consumer has a right 
to choose his/her supplier in that a supplier is not permitted to 
require, as a condition of the supply of any goods or services to 
a consumer, that the consumer must purchase particular goods 
either from that supplier or from another party. Such ‘bundling’ of 
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goods and services is only permitted if the supplier can show that 
the convenience to the consumer outweighs the limitation of the 
consumer’s right to choice, that the bundling results in economic 
benefit for the consumer, or that the bundled goods or services are 
also offered separately.
The Act should also be interpreted to give effect to its stated 
purposes. However, if there is inconsistency with other acts, such 
as the Medicines and Related Substances Act,[3] the two acts will be 
applied together and inconsistencies will be dealt with by applying 
the provision in whichever of the acts affords greater protection to 
the consumer.
Who are the supplier and the 
consumer?
With certain exceptions, the CPA[1] applies to all transactions entered 
into in SA as well as to the promotion and supply of goods and 
services. Pharmacies regularly advertise goods and services and enter 
into transactions for the supply of services such as blood pressure 
monitoring or goods such as medicines, and are therefore deemed to 
be suppliers in terms of the Act.
For the purposes of the CPA,[1] a consumer is a ‘natural person’ 
(i.e. a human being) as well as certain ‘legal persons’ (typically 
companies). A consumer is one to whom goods or services are 
marketed, and/or who enters into a transaction, and/or who is the 
user of goods or the recipient/beneficiary of services. For purposes 
of the supplier’s liability for harm caused by defective products 
(product liability), it is irrelevant whether or not the person who 
has been harmed was a party to the transaction in which the 
goods or services were procured. The result is that a supplier 
(including the manufacturer, an importer, a wholesaler and the 
pharmacy) will be liable to the ‘consumer’ for harm suffered 
as a result of defects in the product supplied, for example to a 
patient who has received free medication. A pharmacy may also 
be considered a consumer because it enters into transactions and 
procures medicines and other goods and services from suppliers. 
A pharmacy belonging to the government or that is a company and 
has an asset value or annual income of ≥R2 000 000 is not regarded 
as a consumer.
Protection afforded by the CPA
A consumer may select goods displayed in open shelves and is not 
responsible for loss or damage of these goods unless this results 
from the consumer’s gross negligence, recklessness, or malicious 
or criminal behaviour. Generally, goods may not be displayed 
for sale unless their prices are also displayed. Prices may be 
displayed in various ways, ranging from being applied to goods 
to being published in relation to goods in a catalogue indicating a 
period during which the prices will be valid. False or misleading 
representations concerning the nature, advantages or price of 
goods or services are prohibited. The Medicines and Related 
Substances Act[3] also deals with false advertisements concerning 
medicines.
Information in notices, documents, promotional offers and 
loyalty programmes must be provided in plain, understandable 
language, taking into account the class of consumer for whom 
such a document is intended. The class of consumer is determined 
by the literacy skill and minimum experience as a consumer of 
the person procuring the goods or services offered. Advantage 
may not be taken of consumers suffering from physical or mental 
disabilities, and no agreements may be made with persons lacking 
legal capacity, such as minors. A consumer must be provided with 
a written record of each transaction regarding supplied goods or 
services. The supplier may not enter into an agreement to supply 
goods/services to a consumer at unfair, unreasonable or unjust 
prices or terms.
Since medicines are inherently unsafe, instructions and warnings 
are extremely important. Information requirements in terms of 
labelling information, package inserts and patient information 
leaflets are laid down in the Regulations to the Medicines and Related 
Substances Act.[4] Furthermore, staff members of a pharmacy dealing 
with consumers should be sufficiently trained before they are allowed 
to advise consumers, as is also recommended in the Good Pharmacy 
Practice guidelines[5] provided by the South African Pharmacy 
Council.
Any consumer has the right to the good-quality service that 
people are generally entitled to expect. The Good Pharmacy 
Practice guidelines[5] also deal with this issue and should be applied. 
If a pharmacy fails to supply good service, the consumer may insist 
on such service or ask for a reasonable refund, depending on the 
extent to which the pharmacy failed. Furthermore, a consumer also 
has the right to good-quality, safe goods without defects, which 
are suitable for the intended purpose and durable. In the situation 
where a consumer communicated the need for goods suitable 
for a particular purpose to the pharmacy and after delivery finds 
the goods unsuitable, they may be returned for a refund within 
10 business days. The refund price may be reduced, for example 
due to consumption, but no reduction is allowed when goods are 
returned unopened and in the original packaging. The CPA[1] will 
not apply in the above circumstances if the return of goods holds a 
threat to public health or is prohibited by a public regulation. The 
return of medicines is not prohibited by the Medicines and Related 
Substances Act.[3]
Unsafe and defective goods may be returned within 6 months 
for repair, replacement or refund without penalty under all 
circumstances. These returned goods can be sent back by the 
pharmacy to the distributors or to other entities in the supply chain 
if the pharmacy meets the requirements of being a consumer. This is 
possible because of an implied warranty of quality that is embodied 
in any transaction or agreement pertaining to the supply of goods 
to a consumer. It is also in line with the Medicines and Related 
Substances Act.[3] However, if the original goods were tampered with, 
for example repacked in the pharmacy, return to the other entities 
in the distribution chain will probably not be possible. It must be 
noted that the Good Pharmacy Practice guidelines,[5] as well as the 
Regulations to the Medicines and Related Substances Act,[4] do allow 
repacking if certain requirements are fulfilled. In terms of returned 
goods, it is clear from the Code of Conduct for Pharmacists[6] and the 
Good Pharmacy Practice guidelines[5] that medicines that have been 
in a patient’s possession and returned must not be redispensed.
A reasonable deposit may be charged in advance for procured 
goods to be collected or delivered at a later date. Advance 
reservations, bookings or orders may be cancelled by a consumer, 
with the exception of special-order goods, such as medicine, that 
the pharmacy was required or expected to procure to satisfy the 
consumer’s requirements and that it does not ordinarily stock. A 
reasonable cancellation fee may be charged depending on factors such 
as the nature of the goods and the length of notice, except in cases of 
death or hospitalisation of the consumer.
Goods must be delivered and services supplied on the date 
agreed upon between the pharmacist and the patient, or within a 
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reasonable time, at the agreed place, as is also clear from the Good 
Pharmacy Practice guidelines.[5] Goods must be delivered at the cost 
of the pharmacy unless expressly otherwise agreed, according to 
the CPA.[1] If delivery takes place on a date or at a place not agreed 
upon, the consumer may require that the delivery takes place as 
agreed upon or cancel the agreement without penalty. The person 
delivering goods to the consumer must be identifiable or provide 
suitable identification. If goods are substituted by other goods, the 
transaction will apply to the substituted goods from the date of their 
delivery and the sales record will have to be amended.
Safety monitoring and recall of goods also forms part of the 
CPA.[1] The Consumer Commission will play a role in the develop-
ment of codes of practice for the investigation of defects of goods, 
warning of the public against these goods, and recall of goods.
Liabilities and remedies
The producer, importer, distributor and retailer of goods are all 
liable if the goods supplied by them were unsafe, defective or 
hazardous, or if inadequate instructions or warnings were provided 
to the consumer. They will be liable for harm in the form of death, 
injury, illness, loss or damage of property, or any economic loss 
experienced by the consumer arising therefrom. Consumers may 
claim from them separately or jointly. It is irrelevant whether they 
were negligent or not. This is often referred to as ‘no-fault liability’ 
or ‘strict liability’.
Complaints of infringement of consumer rights may be lodged 
by any person acting on behalf of him/herself, on behalf of another 
person who cannot act in his/her own name, as a member of, or in the 
interests of, a group or class making class actions possible, or in the 
public interest. An association can act in the interests of its members. 
Consumers have a wide range of options when lodging a complaint. 
Complaints must first be lodged through the supplier’s internal 
procedure where possible, with a relevant ombudsman, or in terms 
of an alternative dispute resolution process where this is provided 
for. If these processes do not result in the resolution of a dispute, a 
complaint can be lodged with the National Consumer Commission 
(NCC) to be investigated further at no cost to the consumer. In time, 
various industry bodies are expected to submit industry codes and 
ombud schemes for approval by the Minister of Trade and Industry. 
Once approved, a consumer will be obliged to make use of such an 
ombud and to await the outcome before escalating the complaint to 
the Commission or the courts.
After investigating a dispute, the NCC may decide to issue a 
compliance notice or to refer the matter to the National Consumer 
Tribunal (NCT) or a consumer court. The Commission may also 
issue a notice of non-referral where complaints are frivolous or 
vexatious. If the matter is referred to the NCT and it is found that 
the consumer’s rights with regard to the CPA have been contravened, 
an administrative fine of up to 10% of the supplier’s annual turnover 
or R1 million, whichever is the greater amount, may be imposed. An 
employer of an employee who infringed a consumer’s rights may be 
held liable separately, or jointly with the employee, for the employee’s 
actions. A pharmacy owner will therefore be liable for infringements 
by staff members.
To prevent complaints from escalating and reaching the NCC 
and the NCT or the court, it is essential for pharmacies to deal 
with possible problems early. Systems should be in place to prevent 
infringements of consumers’ rights or to detect such infringements 
where they do occur. Staff members should be sufficiently trained 
and must be able to deal with consumer complaints effectively 
and as soon as possible. It is also recommended that pharmacies 
advertise their compliance with the CPA to assure the public that 
they have taken the necessary action to adhere to the provisions of 
the Act.[1]
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